Bachem Holding AG (BANB.SW) — Quality & forensics
As of 2026-10-15 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 32
- Quality 40
- Growth 38
- Balance sheet 78
- Cash quality 57
- Capital allocation 47
- Momentum 85
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the BANB.SW chart & overview
FAQ · from the current data · as of 2026-10-15
Quick answers
What is Bachem Holding AG's Closelooknet quality reading?
The composite reads 51/100 across 7 modules, as of 2026-10-15: valuation 32, quality 40, growth 38, balance sheet 78, cash quality 57, capital allocation 47, momentum 85. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Bachem Holding AG's Altman Z-Score?
6.95, which sits in the safe zone (above 2.99) as of 2026-10-15. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Bachem Holding AG's Piotroski F-Score?
6 of 8, as of 2026-10-15. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Bachem Holding AG's Beneish M-Score indicate?
-2.86 — below the −1.78 manipulation-risk threshold, as of 2026-10-15. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- UCB.BR UCB SAindustry
- KRYS Krystal Biotech Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- RPRX Royalty Pharma Plcindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- TWST Twist Bioscience Corpindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- GNS.L Genus PLCindustry